Opportunity Information: Apply for RFA HD 14 034
Apply for RFA HD 14 034
- The National Institutes of Health in the health income security and social services sector is offering a public funding opportunity titled "Male Contraceptive Development Program (U01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.865 Child Health and Human Development Extramural Research.
- This funding opportunity was created on Jun 10, 2014 and posted on Jun 10, 2014.
- Applicants must submit their applications by Aug 11, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities City or township governments County governments Others (see text field entitled Additional Information on Eligibility for clarification) Small businesses Special district governments Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Independent school districts State governments Native American tribal organizations (other than Federally recognized tribal governments).
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Male Contraceptive Development Program (U01) funding opportunity, issued by the National Institutes of Health (NIH) through the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), is designed to support research that moves the field toward a clinically useful way to regulate male fertility. The announcement calls for projects that can span the full research pipeline, including basic discovery work, preclinical development, and clinical research, or a thoughtful combination of these stages. While the overall mission is broad, the core emphasis is on advancing the potential development of a non-hormonal male contraceptive product, meaning applicants are expected to propose work that can realistically contribute to a product that could one day be used in clinical practice rather than stopping at purely descriptive biology.
This opportunity uses a U01 cooperative agreement mechanism, which is different from a standard research grant in that NICHD anticipates having substantial involvement in the project’s direction and progress. In practical terms, awardees should expect an active partnership with the institute, including coordinated planning, agreed-upon milestones, and ongoing programmatic oversight typical of cooperative agreements. The intent is to create a programmatic, translational push where NICHD can help align funded projects with the larger goal of male contraceptive development and help address obstacles that commonly slow product-oriented reproductive research.
The scientific scope is intentionally flexible. Proposed studies could focus on identifying or validating new targets involved in sperm production, sperm function, maturation, or transport, as well as approaches that interfere with fertility in a reversible and safe manner. Projects might include studies that establish proof of concept, develop and test candidate compounds or devices in relevant models, refine delivery methods, evaluate safety and reversibility, or generate data needed to justify or support eventual clinical studies. Clinical-oriented projects are also within scope when they directly support development of a non-hormonal male contraceptive strategy, for example through early clinical evaluation, biomarker development, or studies that address feasibility, pharmacology, or other translational requirements. The key common thread is a clear line of sight to a product that could be clinically useful, with research questions framed around what is needed to advance development rather than only expanding general knowledge.
From an administrative and funding perspective, the FOA is listed as discretionary funding under the Health activity category, with CFDA number 93.865 (Child Health and Human Development Extramural Research). The estimated total funding amount noted in the source data is $1,000,000, and the stated award ceiling is $200,000. No cost sharing or matching is required, which lowers barriers for many organizations by allowing proposed work to be supported without an institutional match.
Eligibility is broad and includes many domestic organization types that commonly apply for NIH funding. Eligible applicants include public and private institutions of higher education, nonprofit organizations (both with and without 501(c)(3) status), for-profit organizations (including small businesses), and a wide range of government entities such as state, county, city/township, special district governments, and public housing authorities/Indian housing authorities. The eligibility list also explicitly encompasses various mission-focused and community-oriented institution categories, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based or community-based organizations and eligible federal agencies. Tribal governments and tribal organizations are included across several categories. At the same time, the opportunity is limited to U.S.-based applicants: non-U.S. (foreign) organizations and foreign institutions are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components (as defined by NIH policy) are not allowed.
The timeline information in the listing shows the FOA was posted and created on June 10, 2014, with an original and current closing date of August 11, 2014, and an archive date of September 11, 2014. While those dates indicate this specific announcement is historical and no longer open, the details still reflect the structure and priorities NICHD used for this program: cooperative agreement funding aimed at product-relevant research to develop a non-hormonal male contraceptive.
For applicants or interested parties who need the full announcement text, the listing provides an additional information link hosted on the NIH Grants Guide website under Funding Opportunity Number RFA-HD-14-034. For technical issues accessing the announcement or linking problems, the contact point provided is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Frequently Asked Questions (FAQs): Male Contraceptive Development Program (U01)
What is the Male Contraceptive Development Program (U01) funding opportunity?
It is an NIH funding opportunity issued through the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to support research that moves the field toward a clinically useful way to regulate male fertility, with a central emphasis on enabling development of a non-hormonal male contraceptive product.
Which NIH institute is sponsoring this opportunity?
The opportunity is sponsored by NICHD, which is part of the National Institutes of Health (NIH).
What is the primary goal of the program?
The primary goal is to advance research that can realistically contribute to a clinically useful, non-hormonal male contraceptive product, rather than stopping at purely descriptive biology.
What does "non-hormonal male contraceptive" mean in the context of this FOA?
Within this program, "non-hormonal" refers to contraceptive strategies intended to regulate male fertility without relying on hormonal manipulation, with an emphasis on approaches that could plausibly translate into a product usable in clinical practice.
What funding mechanism is used, and why does it matter?
This opportunity uses the U01 cooperative agreement mechanism. Unlike a standard research grant, NICHD anticipates substantial involvement in the project’s direction and progress, including coordinated planning, agreed-upon milestones, and ongoing programmatic oversight typical of cooperative agreements.
What should applicants expect from NICHD involvement under a U01 cooperative agreement?
Awardees should expect an active partnership with NICHD, including coordinated planning, milestones that are agreed upon, and ongoing programmatic oversight intended to keep projects aligned with the translational goal of male contraceptive development and to help address common obstacles in product-oriented reproductive research.
What stages of research does the program support?
The FOA allows projects spanning the full research pipeline, including basic discovery research, preclinical development, and clinical research, or a thoughtful combination of these stages.
Is basic research allowed, or must projects be product-focused?
Basic discovery work is within scope, but the emphasis is on research framed around what is needed to advance development toward a clinically useful product. Applicants are expected to maintain a clear line of sight to eventual product development rather than focusing only on descriptive biology.
What kinds of scientific topics and targets are within scope?
The scope is flexible and can include identifying or validating new targets involved in sperm production, sperm function, maturation, or transport, as well as approaches that interfere with fertility in a reversible and safe manner.
What types of studies might be supported under this program?
Examples described include proof-of-concept studies; development and testing of candidate compounds or devices in relevant models; refinement of delivery methods; evaluation of safety and reversibility; and generating data needed to justify or support eventual clinical studies.
Are clinical research projects allowed?
Yes. Clinical-oriented projects are within scope when they directly support development of a non-hormonal male contraceptive strategy, such as early clinical evaluation, biomarker development, or studies addressing feasibility, pharmacology, or other translational requirements.
What is the main theme that ties eligible projects together?
The common thread is a clear, credible path toward a clinically useful product, with research questions centered on advancing development rather than only expanding general knowledge.
What is the CFDA number and activity category for this opportunity?
The listing identifies it as discretionary funding under the Health activity category, with CFDA number 93.865 (Child Health and Human Development Extramural Research).
How much total funding is estimated for this opportunity?
The source data notes an estimated total funding amount of $1,000,000.
What is the stated award ceiling?
The stated award ceiling is $200,000.
Is cost sharing or matching required?
No. The opportunity states that no cost sharing or matching is required.
Who is eligible to apply?
Eligibility is broad and includes many domestic organization types, such as public and private institutions of higher education; nonprofit organizations (with or without 501(c)(3) status); for-profit organizations (including small businesses); and various government entities (state, county, city/township, special district governments, and public housing authorities/Indian housing authorities).
Are minority-serving institutions and community-based organizations included in eligibility?
Yes. The eligibility list explicitly includes categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), and also includes faith-based or community-based organizations.
Are tribal governments and tribal organizations eligible?
Yes. Tribal governments and tribal organizations are included across several categories in the eligibility list.
Are federal agencies eligible to apply?
Yes. The eligibility list includes eligible federal agencies.
Are non-U.S. (foreign) organizations eligible to apply?
No. The opportunity is limited to U.S.-based applicants. Non-U.S. (foreign) organizations and foreign institutions are not eligible to apply.
Can a U.S. organization include a non-U.S. component in its application?
No. The listing states that non-U.S. components of U.S. organizations are not eligible.
Are foreign components allowed under NIH policy for this opportunity?
No. Foreign components (as defined by NIH policy) are not allowed.
When was this FOA posted, and what were the closing and archive dates?
The listing shows the FOA was posted/created on June 10, 2014, with an original and current closing date of August 11, 2014, and an archive date of September 11, 2014.
Is this funding opportunity still open?
No. Based on the provided dates (closing date in 2014 and an archive date in 2014), this specific announcement is historical and no longer open.
What is the funding opportunity number for the full announcement?
The full announcement is identified as RFA-HD-14-034.
Where can applicants find the full text of the announcement?
The listing indicates an additional information link hosted on the NIH Grants Guide website for Funding Opportunity Number RFA-HD-14-034.
Who should be contacted for technical issues with accessing the announcement or link problems?
For technical issues accessing the announcement or linking problems, the contact provided is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same category: Health Income Security and Social Services
Next opportunity: USAID Early Grade Reading and Math Project (USAID RAMP)
Previous opportunity: Assessing the response of juvenile and adult hard clams to the new breach in Great South Bay Post Hurricane Sandy study
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA HD 14 034
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA HD 14 034) also looked into and applied for these:
| Funding Opportunity |
|---|
| Global Omics Approaches Targeting Adverse Pregnancy and Neonatal Outcomes Utilizing Existing Cohorts (R01) Apply for PAR 14 264 Funding Number: PAR 14 264 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Peripheral Blood Biomarkers of Chronic Traumatic Brain Injury in Human Subjects SBIR Direct Phase II (R44) Apply for RFA HD 15 012 Funding Number: RFA HD 15 012 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $750,000 |
| Innovative Therapies and Tools for Screenable Disorders in Newborns (R21) Apply for PAR 14 269 Funding Number: PAR 14 269 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $200,000 |
| Innovative Therapies and Tools for Screenable Disorders in Newborns (R03) Apply for PAR 14 271 Funding Number: PAR 14 271 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $50,000 |
| Pharmacogenetics, Pharmacoepigenetics and Personalized Medicine in Children (R01) Apply for PAR 14 274 Funding Number: PAR 14 274 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Medically Assisted Reproduction Investigation of Mechanisms Underlying the Adverse Outcomes and Development of New and Improved Methods to Overcome the Adverse Outcomes (R01) Apply for PAR 14 272 Funding Number: PAR 14 272 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Medically Assisted Reproduction Investigation of Mechanisms Underlying the Adverse Outcomes and Development of New and Improved Methods to Overcome the Adverse Outcomes (R21) Apply for PAR 14 273 Funding Number: PAR 14 273 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $200,000 |
| Pediatric Cardiac Genomics Consortium (UM1) Apply for RFA HL 15 012 Funding Number: RFA HL 15 012 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $269,000 |
| In vivo Methods for Assessing Placental Development and Function (SBIR) R43/R44 Apply for RFA HD 15 018 Funding Number: RFA HD 15 018 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| In vivo Methods for Assessing Placental Development and Function (STTR) R41/R42 Apply for RFA HD 15 019 Funding Number: RFA HD 15 019 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $2,000,000 |
| Obstetric Fetal Pharmacology Research Centers (OPRC) (U54) Apply for RFA HD 14 013 Funding Number: RFA HD 14 013 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $4,800,000 |
| Patient Safety in the Context of Perinatal, Neonatal, and Pediatric Care (R01) Apply for PA 14 312 Funding Number: PA 14 312 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Patient Safety in the Context of Perinatal, Neonatal, and Pediatric Care (R21) Apply for PA 14 311 Funding Number: PA 14 311 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Patient Safety in the Context of Perinatal, Neonatal, and Pediatric Care (R03) Apply for PA 14 313 Funding Number: PA 14 313 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $50,000 |
| NICHD Consortium for Research on Pediatric Trauma and Injury Prevention (R24) Apply for PAR 14 324 Funding Number: PAR 14 324 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $750,000 |
| Improving Health through Rehabilitation Robotic Technology (R43/R44) Apply for RFA HD 15 001 Funding Number: RFA HD 15 001 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Tools for Assessment and Improvement of Neurologic Outcomes in Perinatal Medicine (R41) Apply for RFA HD 15 005 Funding Number: RFA HD 15 005 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $150,000 |
| Tools for Assessment and Improvement of Neurologic Outcomes in Perinatal Medicine (R43) Apply for RFA HD 15 006 Funding Number: RFA HD 15 006 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $150,000 |
| Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers (U54) Apply for RFA AR 15 002 Funding Number: RFA AR 15 002 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $1,000,000 |
| Biomarkers of Alzheimers Disease in Down Syndrome (R01) Apply for RFA AG 15 011 Funding Number: RFA AG 15 011 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $2,500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA HD 14 034", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.